Our analysis of inflammatory mediators revealed that prediabetic patients demonstrated increased IL-6 levels (p = 0.0001) during acute COVID-19; however, no differences were seen in TNF-a or LTB4 (Figures 1A-C). This evidence concerns the gene IL6 and COVID-19.